Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 1
2001 1
2003 1
2004 1
2005 1
2006 2
2010 1
2012 2
2017 2
2018 2
2019 2
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.
Philis-Tsimikas A, Bajaj HS, Begtrup K, Cailleteau R, Gowda A, Lingvay I, Mathieu C, Russell-Jones D, Rosenstock J. Philis-Tsimikas A, et al. Among authors: russell jones d. Diabetes Obes Metab. 2023 Feb;25(2):331-341. doi: 10.1111/dom.14871. Epub 2022 Oct 14. Diabetes Obes Metab. 2023. PMID: 36106652 Free PMC article. Clinical Trial.
Hormone abuse in sport.
Russell-Jones DL. Russell-Jones DL. Growth Horm IGF Res. 1999 Apr;9 Suppl A:63-5. doi: 10.1016/s1096-6374(99)80012-4. Growth Horm IGF Res. 1999. PMID: 10429883 Review. No abstract available.
Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial.
Davies MJ, Rosenstock J, Ali A, Russell-Jones D, Souhami E, Palmer K, Ji C, Niemoeller E, Skolnik N. Davies MJ, et al. Among authors: russell jones d. Diabetes Obes Metab. 2022 Jan;24(1):34-41. doi: 10.1111/dom.14543. Epub 2021 Oct 6. Diabetes Obes Metab. 2022. PMID: 34617398 Free PMC article. Clinical Trial.
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours.
Russell-Jones G, McTavish K, McEwan J, Rice J, Nowotnik D. Russell-Jones G, et al. J Inorg Biochem. 2004 Oct;98(10):1625-33. doi: 10.1016/j.jinorgbio.2004.07.009. J Inorg Biochem. 2004. PMID: 15458825
Bagnoli, M. Boiocchi, Int. J. Cancer 74 (1997) 193-194; J.A. Reddy, D. Dean, M.D. Kennedy, P.S. Low, J. Pharm. Sci. 88 (1999) 1112-1118; J.A. ...
Bagnoli, M. Boiocchi, Int. J. Cancer 74 (1997) 193-194; J.A. Reddy, D. Dean, M.D. Kennedy, P.S. Low, J. Pharm. Sci. 88 (1999) …
Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.
Herring RA, Shojaee-Moradie F, Garesse R, Stevenage M, Jackson N, Fielding BA, Mendis A, Johnsen S, Umpleby AM, Davies M, Russell-Jones DL. Herring RA, et al. Among authors: russell jones dl. Diabetes Care. 2020 Sep;43(9):2128-2136. doi: 10.2337/dc19-2579. Epub 2020 Jul 8. Diabetes Care. 2020. PMID: 32641376 Clinical Trial.
Participants received dapagliflozin or placebo in random order for 7 days. Stable isotopes were infused to measure the glucose R(a), R(d), and lipolysis. At isotopic steady state, insulin was withdrawn, and the study was terminated after 600 min or earlier if blood glucose …
Participants received dapagliflozin or placebo in random order for 7 days. Stable isotopes were infused to measure the glucose R(a), R(d …
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trial.
Davies MJ, Russell-Jones D, Barber TM, Lavalle-González FJ, Galstyan GR, Zhu D, Baxter M, Dessapt-Baradez C, McCrimmon RJ. Davies MJ, et al. Among authors: russell jones d. Diabetes Obes Metab. 2019 Aug;21(8):1967-1972. doi: 10.1111/dom.13791. Epub 2019 Jun 18. Diabetes Obes Metab. 2019. PMID: 31124299 Free PMC article. Clinical Trial.
22 results